1. Home
  2. PAY vs XENE Comparison

PAY vs XENE Comparison

Compare PAY & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAY
  • XENE
  • Stock Information
  • Founded
  • PAY 2004
  • XENE 1996
  • Country
  • PAY United States
  • XENE Canada
  • Employees
  • PAY N/A
  • XENE N/A
  • Industry
  • PAY Computer Software: Prepackaged Software
  • XENE Biotechnology: Pharmaceutical Preparations
  • Sector
  • PAY Technology
  • XENE Health Care
  • Exchange
  • PAY Nasdaq
  • XENE Nasdaq
  • Market Cap
  • PAY 3.4B
  • XENE 3.3B
  • IPO Year
  • PAY 2021
  • XENE 2014
  • Fundamental
  • Price
  • PAY $26.38
  • XENE $34.26
  • Analyst Decision
  • PAY Hold
  • XENE Strong Buy
  • Analyst Count
  • PAY 6
  • XENE 7
  • Target Price
  • PAY $31.83
  • XENE $57.00
  • AVG Volume (30 Days)
  • PAY 619.5K
  • XENE 454.3K
  • Earning Date
  • PAY 03-10-2025
  • XENE 05-08-2025
  • Dividend Yield
  • PAY N/A
  • XENE N/A
  • EPS Growth
  • PAY 94.45
  • XENE N/A
  • EPS
  • PAY 0.35
  • XENE N/A
  • Revenue
  • PAY $871,745,000.00
  • XENE N/A
  • Revenue This Year
  • PAY $18.50
  • XENE N/A
  • Revenue Next Year
  • PAY $20.14
  • XENE $826.46
  • P/E Ratio
  • PAY $75.17
  • XENE N/A
  • Revenue Growth
  • PAY 41.87
  • XENE N/A
  • 52 Week Low
  • PAY $16.94
  • XENE $33.27
  • 52 Week High
  • PAY $38.94
  • XENE $46.00
  • Technical
  • Relative Strength Index (RSI)
  • PAY 42.00
  • XENE 38.03
  • Support Level
  • PAY $26.43
  • XENE $33.62
  • Resistance Level
  • PAY $28.54
  • XENE $36.25
  • Average True Range (ATR)
  • PAY 1.72
  • XENE 1.22
  • MACD
  • PAY 0.01
  • XENE 0.02
  • Stochastic Oscillator
  • PAY 18.87
  • XENE 22.28

About PAY Paymentus Holdings Inc.

Paymentus Holdings Inc provides electronic bill presentment and payment services, enterprise customer communication and self-service revenue management to billers and financial institutions through a Software-as-a-Service, (SaaS), secure, omni-channel technology platform. The platform integrates into a biller's core financial and operating systems to provide flexible and secure access to payment processing of credit cards, debit cards, eChecks and digital wallets across a number of channels including online, mobile, IVR, call center, chatbot and voice-based assistants. The Company generates revenue from payment transaction fees processed through the Company's platform. The fees are generated as a percentage of transaction value or a specified fee per transaction.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.

Share on Social Networks: